drugset / Trial / NCT03960801

Assessment of Remifentanil for Rapid Sequence Induction and Intubation in Full Stomach Patient Compared to Muscle Relaxant

NCT03960801

Phase 3 Completed 1150 enrolled Nantes University Hospital
RandomizedParallel-groupDouble-blindSupportive care

Summary

REMICrush is a French multicentric non inferiority simple blind randomized clinical trial that will compare the use of Remifentanil to muscle relaxant (reference treatment) for anesthetic rapid sequence intubation in terms of major complications (difficult intubation, gastric liquid aspiration, desaturation, hemodynamics reaction, ventricular arrhythmia, anaphylactic reaction).

Timeline

Start
2019-10-09
Primary completion
2021-04-22
Completion
2021-04-22

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Remifentanil Small molecule 3 ug/kg Intravenous
Subject Remifentanil Small molecule 4 ug/kg Intravenous
Comparator Rocuronium Other / unclassified 1 mg/kg Intravenous
Comparator Suxamethonium Other / unclassified 1 mg/kg Intravenous

Indications

No indication recorded.